FDA Voucher Program to Reduce Drug Review Times, Commissioner Says

Vouchers for a new program will go to companies ‘aligned with U.S. national priorities,’ regulators said.

Dr. Marty Makary, commissioner of the Food and Drug Administration, in Washington on May 5, 2025. Anna Moneymaker/Getty Images

The Food and Drug Administration will complete reviews of certain drugs more quickly, the agency’s commissioner announced on June 17.

FDA Commissioner Dr. Martin Makary said the new Commissioner’s National Priority Voucher program will help reduce the time the agency spends reviewing final applications for drugs.